| Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection V Bihrer, M Friedrich-Rust, B Kronenberger, N Forestier, J Haupenthal, ... Official journal of the American College of Gastroenterology| ACG 106 (9 …, 2011 | 237 | 2011 |
| High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis F Finkelmeier, Ö Canli, A Tal, T Pleli, J Trojan, M Schmidt, ... European journal of cancer 59, 152-159, 2016 | 225 | 2016 |
| Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma V Koeberle, B Kronenberger, T Pleli, J Trojan, E Imelmann, ... European Journal of Cancer 49 (16), 3442-3449, 2013 | 224 | 2013 |
| Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers V Köberle, T Pleli, C Schmithals, E Augusto Alonso, J Haupenthal, ... PloS one 8 (9), e75184, 2013 | 209 | 2013 |
| Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients H Farnik, J Bojunga, A Berger, R Allwinn, O Waidmann, B Kronenberger, ... Hepatology 58 (4), 1270-1276, 2013 | 186 | 2013 |
| Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma V Bihrer, O Waidmann, M Friedrich-Rust, N Forestier, S Susser, ... PloS one 6 (10), e26971, 2011 | 168 | 2011 |
| Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection O Waidmann, V Bihrer, T Pleli, H Farnik, A Berger, S Zeuzem, ... Journal of viral hepatitis 19 (2), e58-e65, 2012 | 165 | 2012 |
| Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis G Dultz, A Piiper, S Zeuzem, B Kronenberger, O Waidmann Alimentary pharmacology & therapeutics 41 (5), 459-466, 2015 | 149 | 2015 |
| Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis O Waidmann, F Brunner, E Herrmann, S Zeuzem, A Piiper, ... Journal of hepatology 58 (5), 956-961, 2013 | 131 | 2013 |
| High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma D Bergis, V Kassis, A Ranglack, V Koeberle, A Piiper, B Kronenberger, ... Translational oncology 6 (3), 311-318, 2013 | 128 | 2013 |
| Tumor regression by combination antisense therapy against Plk1 and Bcl-2 R Elez, A Piiper, B Kronenberger, M Kock, M Brendel, E Hermann, ... Oncogene 22 (1), 69-80, 2003 | 121 | 2003 |
| Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity MW Welker, D Reichert, S Susser, C Sarrazin, Y Martinez, E Herrmann, ... PloS one 7 (2), e30796, 2012 | 107 | 2012 |
| Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth … A Piiper, I Dikic, MP Lutz, J Leser, B Kronenberger, R Elez, H Cramer, ... Journal of biological chemistry 277 (46), 43623-43630, 2002 | 107 | 2002 |
| Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma–a prospective cohort study F Finkelmeier, B Kronenberger, V Köberle, J Bojunga, S Zeuzem, J Trojan, ... Alimentary pharmacology & therapeutics 39 (10), 1204-1212, 2014 | 100 | 2014 |
| Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial T Berg, B Kronenberger, H Hinrichsen, T Gerlach, P Buggisch, ... Hepatology 37 (6), 1359-1367, 2003 | 99 | 2003 |
| Serum microRNA-122 predicts survival in patients with liver cirrhosis O Waidmann, V Köberle, F Brunner, S Zeuzem, A Piiper, B Kronenberger Public Library of Science 7 (9), e45652, 2012 | 96 | 2012 |
| Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy WP Hofmann, A Polta, E Herrmann, U Mihm, B Kronenberger, T Sonntag, ... Gastroenterology 132 (3), 921-930, 2007 | 95 | 2007 |
| Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response S Christoph, T Berg, JH Lee, B Rüster, B Kronenberger, WK Roth, ... The Journal of infectious diseases 181 (2), 432-441, 2000 | 94 | 2000 |
| Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C: signal amplification at … A Piiper, R Elez, SJ You, B Kronenberger, S Loitsch, S Roche, S Zeuzem Journal of biological chemistry 278 (9), 7065-7072, 2003 | 90 | 2003 |
| Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response C Sarrazin, I Kornetzky, B Rüster, JH Lee, B Kronenberger, K Bruch, ... Hepatology 31 (6), 1360-1370, 2000 | 88 | 2000 |
